» Authors » Isabelle Fournier

Isabelle Fournier

Explore the profile of Isabelle Fournier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 188
Citations 2894
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kallianioti A, Bourdon G, Grandhaye J, Chevaleyre C, Aboulouard S, Pechoux C, et al.
Endocrinology . 2025 Feb; 166(3). PMID: 39953803
Overconsumption of fructose is linked to metabolic diseases, which are often associated with reduced fertility. GLUT5 is the most specific fructose transporter. To investigate its role in the testes, we...
2.
Mercadie A, Gravier E, Josse G, Fournier I, Viode C, Vialaneix N, et al.
Bioinformatics . 2025 Feb; 41(2). PMID: 39921890
Motivation: The development of high-throughput sequencing enabled the massive production of "omics" data for various applications in biology. By analyzing simultaneously paired datasets collected on the same samples, integrative statistical...
3.
Lagache L, Zirem Y, Le Rhun E, Fournier I, Salzet M
Mol Cell Proteomics . 2024 Dec; 24(1):100891. PMID: 39644924
Prediction of proteins and associated biological pathways from lipid analyses via matrix-assisted laser desorption/ionization (MALDI) MSI is a pressing challenge. We introduced "dry proteomics," using MALDI MSI to validate spatial...
4.
Ziane-Chaouche L, Raffo-Romero A, Hajjaji N, Kobeissy F, Pinheiro D, Aboulouard S, et al.
Cell Death Dis . 2024 Dec; 15(12):879. PMID: 39632807
Chimeric antigen receptor (CAR)-T-cell therapy has revolutionized cellular immunotherapy, demonstrating remarkable efficacy in hematological cancers. However, its application in solid tumors faces significant challenges, including limited T-cell infiltration and tumor-induced...
5.
Zirem Y, Ledoux L, Salzet M, Fournier I
STAR Protoc . 2024 Sep; 5(3):103285. PMID: 39235938
In context of cancer diagnosis-based mass spectrometry (MS), the classification model created is crucial. Moreover, exploration of immune cell infiltration in tissues can offer insights within the tumor microenvironment. Here,...
6.
Laguillaumie M, Titah S, Guillemette A, Neve B, Lepretre F, Segard P, et al.
Biol Res . 2024 Sep; 57(1):59. PMID: 39223638
Background: Tumour dormancy, a resistance mechanism employed by cancer cells, is a significant challenge in cancer treatment, contributing to minimal residual disease (MRD) and potential relapse. Despite its clinical importance,...
7.
Ogrinc N, Barka E, Clement C, Salzet M, Sanchez L, Fournier I
Anal Chem . 2024 Aug; PMID: 39155838
There is growing interest in limiting the use of fungicides and implementing innovative, environmentally friendly strategies, such as the use of beneficial bacteria-triggered immunity, to protect grapevines from natural pathogens....
8.
Ozcelik F, Dundar M, Yildirim A, Henehan G, Vicente O, Sanchez-Alcazar J, et al.
Funct Integr Genomics . 2024 Aug; 24(4):138. PMID: 39147901
Artificial intelligence (AI) platforms have emerged as pivotal tools in genetics and molecular medicine, as in many other fields. The growth in patient data, identification of new diseases and phenotypes,...
9.
Gomez-Murcia V, Launay A, Carvalho K, Burgard A, Meriaux C, Caillierez R, et al.
Brain . 2024 Jul; 147(8):2691-2705. PMID: 38964748
Early pathological upregulation of adenosine A2A receptors (A2ARs), one of the caffeine targets, by neurons is thought to be involved in the development of synaptic and memory deficits in Alzheimer's...
10.
Bellavance S, Khoury M, Fournier I, Costisella J, Lapointe A, Giguere C, et al.
Laryngoscope . 2024 Jul; 134(12):5178-5183. PMID: 38958053
Objectives: Tympanostomy tube insertion (TTI) under local anesthesia (LA) is gaining popularity but literature comparing long-term outcomes for children undergoing TTI under LA versus general anesthesia (GA) is limited. This...